Back
Day Range
$72.47
$75.70
52-Week Range
$23.18
$123.75
Volume
176,561
50D / 200D Avg
$81.08
/
$58.29
Prev Close
$71.62
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -46.0 | 0.4 |
| P/B | 6.9 | 2.9 |
| ROE % | -27.9 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$136.50
+88.4%
Low: $126.00
High: $147.00
Forward EPS
-$4.76
Est. Revenue
0
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$4.82
-$4.82 – -$4.82
|
110 M | 1 |
| FY2029 |
-$7.41
-$7.41 – -$7.41
|
110 M | 1 |
| FY2028 |
-$9.50
-$12.70 – -$5.66
|
36 M | 5 |
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-27.93%
ROIC-12.72%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio36.10
Interest Coverage0.00
Valuation
P/E Ratio
-45.99
P/B Ratio6.86
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -12.23M |
| ROE | -27.93% | ROA | -14.49% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | N/A |
| ROIC | -12.72% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 36.10 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -45.99 | P/B Ratio | 6.86 |
| P/S Ratio | N/A | PEG Ratio | -0.27 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 562.48M | Enterprise Value | 479.69M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -12.23M | -2.80M | -7.37M | -14.96M | -8.65M |
| EPS (Diluted) | -1.78 | -0.65 | -1.98 | -6.15 | -4.74 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -13.94M | -2.82M | -7.39M | -14.98M | -8.62M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 84.42M | 6.10M | 6.88M | 12.09M | 20.04M |
| Total Liabilities | 2.38M | 568,259.0 | 280,856.0 | 1.54M | 638,573.0 |
| Shareholders' Equity | 82.04M | 5.54M | 6.60M | 10.54M | 19.40M |
| Total Debt | 125,777.0 | 118,960.0 | 73,549.0 | 139,911.0 | 0.0 |
| Cash & Equivalents | 82.91M | 5.72M | 6.75M | 11.63M | 19.76M |
| Current Assets | 84.31M | 5.99M | 6.81M | 11.95M | 20.04M |
| Current Liabilities | 2.34M | 528,683.0 | 280,856.0 | 1.47M | 638,573.0 |